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Abstract 
Treatment modalities for neonates born with congenital diaphragmatic hernia (CDH) have greatly 
improved in recent times with a concomitant increase in survival. In 2008, CDH EURO Consortium, a 
collaboration of large volume CDH centres in Western Europe, was established with a goal to 
standardise management and facilitate multi-centre research. However, limited knowledge on long-
term outcomes restricts identification of optimal care pathways for CDH survivors in adolescence and 
adulthood. This review is aimed to evaluate the current practice of long-term follow-up within the CDH 
EURO Consortium centers, and to review the literature on long-term outcomes published from 2000 
onwards. Apart from having disease-specific morbidities, children with CDH are at risk for impaired 
neurodevelopmental problems and failure of educational attainments which may affect participation in 
society and the quality of life in later years. There is thus every reason to offer them long-term 
multidisciplinary follow-up programs. We discuss a proposed collaborative project using Standardised 
Clinical Assessment and Management Plans (SCAMP) methodology to obtain uniform and 
standardized follow-up of CDH patients at an international level.  
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Introduction 
In 2008, the Section on Surgery and the Committee on the Fetus and Newborn of the American 
Academy of Pediatrics (AAP) published an overview of the post-hospital discharge long-term 
sequelae of infants with congenital diaphragmatic hernia (CDH).(1) However, many of these studies 
were performed several decades ago, in an era before standardized postnatal management was 
introduced, and most studies focus on outcome in the first years of life. 
Meanwhile, the survival rates for neonates born with CDH have increased significantly as 
management strategies have evolved.(2, 3) The “price of success”, however, appears to be an 
increase in long-term morbidity. Chronic pulmonary obstruction and pulmonary vascular disease, 
neurodevelopmental and hearing impairment, gastro-intestinal dysfunction, in addition to late general 
surgical and orthopaedic complications are increasingly described.(2, 4)  
In 2012, Chiu and IJsselstijn reviewed the long-term outcomes of survivors with CDH and reported the 
results of a web-based survey to evaluate how many of the 60 participating centers in the CDH Study 
Group had long-term follow-up in place. Of the 22 (37%) centers that responded, structured follow-up 
was performed in only 16 (73%).(5)  
In 2008, a collaboration of large volume CDH centres in Western Europe led to the establishment of 
the CDH Euro consortium with the goals of standardizing care, and facilitating the conduct of multi-
site randomized controlled trials and structured prospective data collection. One of the first 
developments within the Consortium was the consensus agreement of a standardized postnatal 
management protocol.(6) This permitted the group to perform the first randomized controlled trial in 
CDH patients(7), with subsequent revision of the consensus.(8) 
Despite the successful efforts to provide standardized care to CDH patients, accurately assessing the 
impact of such interventions is extremely challenging without having standardized long-term follow-
up.(9) Moreover, this lack of knowledge on long-term outcomes will impede optimal care for older 
CDH survivors.  
In 2010, Rathod et al. proposed a novel methodology to aid the rationalisation of clinical management 
and permit evolution of care pathways.(10) These “Standardised Clinical Assessment and 
Management Plans” (SCAMPs) are founded on the understanding that most clinical decisions are not 
necessarily evidence-based, and that there must be provision for flexibility in relation to changing 
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practice. To inform such a change, however, assessment and management must be tightly structured 
and standardised, and data collected using clearly defined unambiguous treatment algorithms. This 
permits the exploration of hypotheses which are embedded a priori. As CDH is a rare disease, 
multicentre collaboration is mandatory to apply the SCAMP methodology successfully. We 
hypothesized that initiation of SCAMPs would be possible within the framework of the CDH EURO 
Consortium. 
The aims of this study were 1) to evaluate the current practice of long-term follow-up within the CDH 
EURO Consortium centers, 2) to review literature by system on outcomes in CDH published from 
2000 onwards, and 3) to discuss SCAMP methodology as a potential approach to obtain uniform and 
standardized follow-up of CDH patients.  
 
Methods 
Survey 
We developed a two-part web-based questionnaire. Part 1 aimed at gathering background information 
and understanding broadly the follow-up practices in participating centers. Part 2 aimed specifically at 
understanding the current follow-up practice in those centers with a structured CDH follow-up 
program. One representative from each of the 20 participating centers was contacted by e-mail and 
invited to co-ordinate completion of the survey on behalf of their institution. The survey was 
deliberately concise with both multiple choice and open-ended questions. It was unanimously 
approved at a meeting of the follow-up working group within the CDH EURO Consortium in April 
2016.  
Literature review 
We defined, by consensus, seven areas of interest with respect to long-term morbidities: pulmonary 
function, pulmonary hypertension (PH), neurodevelopment, sensorineural hearing loss (SNHL), 
growth and gastrointestinal morbidities, general surgical outcomes and musculoskeletal outcomes. 
We conducted an extensive literature search from 2000 onwards (Supplementary File S1). Since the 
main goal of the literature review was to explore unanswered questions we decided not to use the 
systematic literature review methodology. Based on title and abstract, articles were categorized and 
included for evaluation. Members of the working group, focusing on their area of expertise, 
summarized the current knowledge base in predefined tables delineating the most important issues. 
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Results  
Survey 
Nineteen centers answered the first part of the survey in its entirety (95%). Among the respondents 
were nine neonatologists (47%), seven pediatric surgeons (37%), one pediatrician (5%), one pediatric 
intensivist (5%), and one obstetrician (5%). The annual case volume of responding centers is shown 
in Figure 1.   
All centers reported that CDH patients were followed up at their institution, however, 4/19 (21%) 
respondents reported that follow-up was not structured and standardized. Two centers discontinued 
structured follow-up at 1 year of age. The reasons provided were: lack of resources or personnel, or a 
large catchment area.  
Three centers (16%) endorsed following up all CDH patients routinely, whereas 16 centers (84%) 
supported review of only those at highest risk of morbidity. The presence of chronic lung disease was 
selected as the most important risk factor (94%; Table 1). All respondents unanimously agreed and 
endorsed standardization of follow-up and were willing to adopt such a collectively agreed pathway 
within the EURO Consortium. 
 
Fifteen participating centers answered the second part of the survey (79%); 13 provided follow-up 
standardized both for time points and data collection (87%), the remainder (13%) for time points 
alone. A summary of the follow-up services currently provided is shown in Table 2. None of the 
centers performed annual follow-up until 16 years of age; only one center offered annual review until 
10 years of age. Only half of the centers performed follow-up after the age of 12 years (Table 2). For 
the 5 centers that provided follow-up until 16-20 years, the time intervals between reviews were 
usually 3-6 months within the first two years of life, with wider intervals of up to 2-6 years once school 
aged.  
Pulmonary assessments 
In 11 centers (73%) chest radiographs were performed routinely in every CDH patient; in 5 of those 
(33%) within the first year of life only. In three centers (20%) follow-up chest radiographs were taken 
routinely but restricted to CDH patients repaired with a patch. One center that applied pH-metry 
routinely at 0.5 and 8 years carried out chest radiographs for assessing tube position and 
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diaphragmatic integrity. One center which offered fetal tracheal occlusion, performed a chest CT 
routinely at one year of age. One center performed chest MRIs routinely at 2 and 10 years of age. 
Two centers performed routine pulmonary function testing within the first year of life; in 5 other 
centers, pulmonary function testing was done in childhood. One center discontinued pulmonary 
function testing after the age of 6 years, whereas the 4 other centers performed repeated 
measurements at 4-5 year intervals at older ages.  
Cardiac assessments 
Four centers performed routine echocardiograms within the first year of life irrespective of the 
presence of pulmonary hypertension prior to discharge. In one of those centers, evaluations at 5 and 
12 years were scheduled for those with pulmonary hypertension identified at 1 year. One other center 
restricted routine echocardiograms to those with chronic pulmonary hypertension. Two centers 
evaluated pulmonary hypertension at 14 or 16 years; one of these centers provided routine 
echocardiograms every 2 to 4 years after the age of 2 years.  
Neuro-imaging and neurodevelopmental assessments 
Only one center provided routine cranial MRI (at 2 and 10 years). Hearing assessments were offered 
routinely after discharge in 6/19 centers (32%); two centers performed hearing assessments after the 
age of 5 years. One center offered hearing assessments every 6 months until 6 years of age. Routine 
neurodevelopmental assessments were performed until 2 years in half of the participating centers; in 
5/19 centers (26%) it was carried out until 5 years of age. Two centers offered routine 
neuropsychological assessments after 5-6 years of age.  
Anthropometry and gastro-intestinal studies 
All participating centers evaluated height and weight at each assessment. Upper gastrointestinal 
studies to evaluate reflux were routinely performed after discharge in 6/19 (32%) centers; one center 
did this at school age (8 years). Esophagoscopy was offered in one center prior to discharge. A single 
center reported screening for oral aversion at each hospital visit.  
Other investigations 
Specific orthopedic assessment for chest wall deformities was reported by two centers.  
 
We now present the literature review on these long-term morbidities in CDH survivors.  
Literature review 
Page 7 of 98
https://mc04.manuscriptcentral.com/prjournal
Pediatric Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
Pulmonary function 
A literature overview is provided in Supplementary Table S1. Follow-up studies assessing pulmonary 
symptoms in  CDH  have yielded conflicting results. Wheeze and recurrent cough are reported in 
approximately 10-50% of pre-school children.(11-14) Asthma appears to be more prevalent in 
survivors and is reflective of malformation severity.(15, 16) Symptoms of obstructive airways appear 
to abate with age despite persistence of airflow obstruction on objective measurement.(17) . Indeed, 
those assessed at  mid (4.5+1.8years) and long-term (21+5.7 years) by Arena et al, reported, no 
respiratory symptoms.(17) 
CDH survivors have been reported to suffer from recurrent respiratory tract infections(15, 18), but 
whether this is greater than in other term born, ventilated infants is unclear. Respiratory syncytial virus 
(RSV) infection may be severe in CDH patients necessitating hospitalisation and sometimes further 
surgery.(18) Pneumonia has been reported in 7% of CDH patients during infancy both due to infection 
and aspiration.(1) 
Regarding functional residual capacity (FRC) in infancy,  reduced, normal and even increased  FRC 
are reported.The latter reflecting compensatory over-inflation of the contralateral lung.(19-21) 
Additionally, lower tidal volume, higher resistance and lower compliance of the respiratory system   
are reported in infancy.(21-23) Conversely, persistent obstructive and restrictive abnormalities are  
described in older children.(24-28) At eight years of age, CDH survivors had comparatively lower 
forced vital capacity (FVC), forced expiratory volume at one second (FEV1) and mean forced 
expiratory flow between 25% and 75% of the FVC (FEF25-75 ).(28) In another study, at eight years of 
age the majority had normal lung function (27) whereas at 11.9 years lower FEV1, FVC and 
FEV1/FVC results were reported.(26) Twenty-six CDH adolescents and 30 controls born between 
1985-1991 (mean age of 13 years at follow-up) demonstrated significant differences in FEV1, FEF 25-
75, FRC, residual volume/total lung capacity (RV/TLC) and maximal voluntary ventilation (MVV) and 
reduced muscle strength. A correlation between lung function results and body mass index  has been 
reported.(16, 29) At a mean age of 24.3 years 12 young people had a lower FEV1, although their 
quality of life was comparable to the general population.(30) Hyperpolarised 3He magnetic resonance 
(3HeMR) and anatomical 1H magnetic resonance imaging (1HMRI) studies in those 28 years of age 
have shown functional changes persist into adulthood.(31)  
Page 8 of 98
https://mc04.manuscriptcentral.com/prjournal
Pediatric Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
Opt-electronic plethysmography in 14 children demonstrated significant thoraco-abdominal and trans-
thoracic asynchrony and a marked asymmetry in the expansion of the pulmonary rib cage. In those 
who had a patch repair, the overall diaphragmatic contribution to breathing was significantly 
reduced.(32) 
Ninety-eight patients aged between 11 days and 44 months had pulmonary function testing between 
one and five occasions using the raised volume rapid compression technique. Forced expiratory flows 
were below normal and residual volumes and FRCs were elevated.(19) In another series, there was 
catch up of lung volume, but airflow remained significantly reduced. In 27 CDH and 30 controls (mean 
age 26.8 years at last follow-up), a longitudinal study demonstrated mild deterioration in airflow 
obstruction and diffusion capacity since 11.8 years.(33) 
Reduced exercise performance is reported in CDH survivors, but may improve with increasing age. At 
five years of age CDH patients had reduced FEV1 and maximal exercise performance.(34) Exercise 
testing at seven years revealed lower anaerobic exercise capacity in CDH children than controls. Self-
reports on daily activities may identify CDH survivors with low maximum peak oxygen consumption 
and thus identify those who may benefit from physical training.(35)  In one study, 10-16 year old 
survivors born in 1985-1991 had mildly reduced exercise capacity, although cardiorespiratory 
response to exertion was similar to controls.(36) Amongst 27 CDH and 30 controls treated for 
neonatal respiratory failure all born at term, similar levels of exercise capacity, daily activity and 
fatigue were seen at a mean age of 26.8 years.(37) Whether reduced exercise capacity impacts 
unfavourably remains controversial. At 6.6 years, those CDH children who had a higher level of 
exercise performance had less perception of dyspnoea and effort.(38) 
Ventilation perfusion of the ipsilateral lung has been reported in those with pulmonary morbidity and 
lower body weight at one and two years of age.(39) Sixty-one percent of 46 patients who had at least 
two scans at a mean age of 1.3 years and 6.3 years had abnormal scans.(40) (15). An association 
between patch repair and V/Q mismatch has been reported.(25, 40)  
 
Pulmonary hypertension 
The incidence and course of PH in children after CDH repair has been studied in a limited number of 
observational studies (Supplementary Table S2). The underlying pathophysiology and natural history 
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of PH in CDH are not well understood. Although a number of mediators of smooth muscle tone and 
vascular development have been identified (nitric oxide-VEGF pathway, endothelin and prostacyclin 
pathways), subclassification based on these, or other criteria, is not currently possible. There are no 
agreed standards to stratify PH in CDH per se. A variety of stratifications have been employed, based 
on echocardiographic assessment of pulmonary arterial pressures (PAP).(27, 41-45) 
Whether the functional and structural abnormalities of the pulmonary vasculature at birth improve or 
deteriorate through childhood and beyond is  unknown. Observational studies with small numbers of 
patients have assessed PAP and cardiac function in childhood survivors. At three weeks of age 51% 
of cases had a PAP of at least half systemic blood pressure.(46) In another study the median  age of 
“resolution” of PH in infants with CDH was 14 (7-21) days with moderate or severe PH in 11% at 
discharge.(41) Behrsin and coworkers reported that 17% of infants with repaired CDH were 
discharged on sildenafil.(47) Approximately 40% of CDH survivors are reported to have 
echocardiographic evidence of PH in the first 3 years of life.(42) Echocardiographic studies in older 
survivors (6-11 years) have not observed raised PAP.(25, 27) However, evidence of RV dysfunction 
has been observed  at 7 years of age.(43) Cardiac catheterisation studies have demonstrated 
elevated pulmonary vascular resistance and PAP in CDH survivors up to 12 years of age.(42, 48) 
Although these studies suggest that chronic PH can occur after CDH repair, they are limited by study 
size, variation in treatment eras, and illness severity. They also highlight the current lack of 
standardised definitions of PH, diagnostic techniques, and prospective multi-centre data collection. 
 
Neurodevelopment 
Despite arguably creating the greatest patient burden, neurodevelopmental morbidity from CDH has, 
until recently been under-reported due to limited follow-up. Additionally, standardized assessments 
cannot be performed in children with severe disabilities. A literature overview is provided in 
Supplementary Table S3.  
From infancy until school age, normal scores for cognition have been reported in CDH survivors. 
Overall, the cognitive and language development scores at preschool age are normal to mildly 
delayed(9, 49-54)with ECMO exposure an independent predictor of impaired mental 
development.(50, 52, 55) 
Page 10 of 98
https://mc04.manuscriptcentral.com/prjournal
Pediatric Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
The findings across published studies are difficult to compare because of variability in age at 
assessment and study design. In CDH survivors Danzer(56) reported that 44% of infants had mild, 
and 13% severe neurodevelopmental delays in at least one domain at 1 year of age. Benjamin 
reported that 44% were at risk for neurocognitive delay at median age of 4.9 years.(57)  
At school age, intelligence appears in the average range.(58-63) with only a single Japanese study 
reporting overall low intelligence in a cross-sectional cohort of 6-17 year-olds.(64) Despite overall 
average cognition, many children (up to 50%) struggle in standard educational programs.(63) By 
school age survivors also experience concentration/attention problems.(59, 63) ECMO-treated CDH 
patients have significantly lower scores on visual motor integration compared with neonatal ECMO 
controls.(62) Other studies report normal(59) to slightly impaired scores(55, 58) on visual motor 
integration. The children report that their perception of general health is reduced when compared to 
the reference norm(65, 66), positively they report a well-developed feeling of self-confidence.(63, 66) 
Such neurocognitive delays  recorded in earlier life may improve.(55)  
Data on motor function in children with CDH is scarce, but problems occur in approximately 40% of 
children at preschool age and 20-30% at school age. Preschool motor development scores in CDH 
patients are usually reported to be normal or subnormal(9, 49, 51-53, 55, 61, 67) seeming to improve 
between 1 and 3 years of age.(51, 53) In a population of 47 CDH patients of whom 26% received  
ECMO, mild to severe motor function delay was reported in 45% and 19% at 1 and 3 years, 
respectively.(51) At 5 years 47% of ECMO-treated CDH patients had normal motor function; the 
remaining 53% had gross delays.(60) In another study, 58% of 5-year-olds, both with and without 
need for ECMO, had normal motor function.(68) In a cross-sectional cohort of 15 non-ECMO treated 
CDH-patients aged 6-15 years old Tureczek and co-workers observed gross motor function problems 
in 80%, whereas motor performance was normal in all 8 participants aged 3-5 years in the same 
study.(61) Although motor function seems to improve at the age of 8 years(63, 69), it deteriorates 
when the children get older.(69) This suggests that CDH patients grow into their deficits when tasks 
become more complex.  
 
Sensorineural hearing loss 
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SNHL is the most common sensory deficit in humans with a prevalence ranging from 1.5 to 6.0 per 
1000 live births(70) with a tenfold higher prevalence (1% to 3%) in those who require neonatal 
intensive care.(71) A literature overview is provided in Supplementary Table S4.  
In patients with CDH, SNHL has been reported with a variable prevalence, ranging from 0%(72) to 
100%.(73) Although earlier studies tend to present a higher prevalence of SNHL, Amoils and co-
workers report a prevalence of SNHL over 50% in 2015.(74) Controversies exist on the impact of the 
diagnosis of CDH on the risk of SNHL development. In a study on 111 ECMO graduates, Fligor and 
co-workers reported a 26% overall prevalence of SNHL in neonates with severe respiratory distress 
and described CDH as an independent risk factor.(75) Conversely, a more recent study of 136 ECMO 
survivors observed a prevalence of 9% of SNHL, irrespective of the underlying diagnosis.(76) As far 
as the natural history is concerned, in CDH patients SNHL tends to present as late-onset and 
progressive. Most studies with data from neonatal hearing screening, report normal findings.(73, 74, 
77-81) Therefore, the extreme variability in length of follow-up in available reports,  precludes firm 
conclusions on the actual prevalence. 
The most frequently reported factors associated with SNHL are ECMO treatment(74, 75, 82, 83), 
length of mechanical ventilation and/or stay in the NICU or in hospital(74, 78, 79, 83-85), need for 
inhaled nitric oxide(84), patch repair(74), and dose and duration of specified drugs: loop diuretics(74, 
78, 82-84), aminoglycosides(75, 83, 84) and pancuronium bromide(78, 84) Overall, these factors 
suggest that the most critically ill CDH patients are at  greatest risk. Identifying definite factors that 
place CDH patients at high risk for SNHL will permit their modification and may aid prognostication. 
 
Gastrointestinal morbidity and growth 
CDH related gastrointestinal morbidity is common.(86) The main morbidities are oral aversion (OA), 
need for tube feeding (NFT), failure to thrive (FTT), and gastro-esophageal reflux disease (GERD) 
(Supplementary Table S5).  
Slower growth velocity in infants with CDH during the early postnatal period is described.(22) 
Approximately 20-30% experience FTT within the first years of life which may persist into 
adolescence.(87, 88) However, Gien and coworkers revealed the highest risk for comorbidities at both 
extremes of growth velocity.(89) Leeuwen and co-workers observed stunting and wasting up to 12 
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years of age, although growth failure became less prevalent after correcting for individual target 
height.(88) Several risk factors expressing the severity of CDH have been identified: the intensity of 
respiratory support, ECMO use, and oxygen supplementation at discharge.(90-92) Data about the 
underlying mechanism for FTT in CDH are scarce. Increased work of breathing, OA, GERD and acute 
metabolic stress have been identified as contributing factors.(93-95)  
A recent study demonstrated that 58% of infants with CDH were in a hypermetabolic state measured 
by indirect calorimetry  supporting the need for increased caloric intake for appropriate growth.(90) 
The best nutritional strategy for these infants is uncertain and an individually tailored approach is 
generally used. The optimal growth targets for this population remain unidentified, and whether a 
strategy of hyperalimentation risks later cardiovascular disease.(96)  
GER is present in up to  86% of  infants with CDH in the first year of life.(97) Ascertaining whether 
GER is pathologic or not is a key.issue. Identified risk factors include: antenatal diagnosis, 
intrathoracic liver position, patch closure, stomach position, esophageal dysmotility and  tube feeding 
at discharge.(98-100) Gastrointestinal symptoms (GERD, FTT, OA) are associated with a longer 
hospital course, prolonged mechanical ventilation and a longer need for parenteral nutrition.(101) The 
diagnostic approach for suspected GERD in infants with CDH should be based on standard 
guidelines.(102) Therapeutic approaches include proton pump inhibitors and surgical fundoplication. 
In one study the need for anti-reflux surgery related to gestational age and defect size.(101) Not all 
infants demonstrate improvement in anthropometric scores following treatment.(87) GERD can lead 
to worsening of chronic lung disease, aspiration pneumonia, malnutrition and FTT. Its presence has 
an effect on quality of life.(16) There are a few studies on primary anti-reflux surgery and its effect on 
growth and GERD with conflicting results.(101, 103) Patients without prophylactic antireflux surgery 
typically undergo this treatment before 6 months of age.(104) The long term outcome of GERD in 
CDH patients is unclear. However, Barrett’s esophagus and esophageal adenocarcinoma have been 
described in CDH patients.(105) 
The reported incidence of OA is as high as 25%; the underlying etiology is largely unknown.(16, 72) It 
has been suggested that the endotracheal tube might interfere with the development of a normal 
swallow .(94) The incidence of OA in patients with CDH is associated with a more severe postnatal 
clinical course. Early aggressive intervention failed to reduce its incidence.  
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NTF is described in association with FTT in CDH patients. Data on its use are scarce with a reported 
incidence between 18 and 70%, and an association with markers of disease severity.(13, 90, 93)  
 
General surgical morbidity 
Long-term general surgical morbidities include recurrence of the diaphragmatic defect, chronic patch 
infections, and volvulus in those with rotational anomalies (Supplementary Table S6). 
All literature reports identified were retrospective, mostly single centre and with variable follow-up time 
points. Hence, comparison across studies is not feasible. Small defects (A and most of B according to 
the CDH Study Group Staging System(106) are closed primarily by direct non-absorbable sutures. In 
large defects (large B, C or D) a patch is typically employed. The risk for recurrence relates to closure 
technique – which are not standardised (107-112), liver position(113), and patch material.(112) 
Minimally invasive surgery (MIS) has become more common, with a corresponding increase in 
recurrence rates.(108, 114, 115) Up to 2/3 of recurrences are found incidentally. Plain x-ray does not 
have a high sensitivity for detecting recurrences, but remains the most commonly used diagnostic 
tool. 
The incidence of small bowel obstruction may be higher with patch closure (113) but reports are 
contradictory.(110) A MIS approach may be protective.(116) 
Infectious complications are seldom encountered and conservative therapy with antibiotics seems to 
be appropriate.(110)  
Data on malrotation management and need for follow-up in children with CDH are lacking. Only two 
studies report on volvulus(109, 117) with a prevalence of 0.3% when no Ladd’s procedure was 
performed.(117) 
 
Musculoskeletal morbidity 
Until recently there have been few reports on musculoskeletal morbidity in CDH patients 
(Supplementary Table S7). Whereas the prevalence of idiopathic scoliosis at school age is 
approximately 0.5%(118), it was reported in 2 to 26% in children with CDH. However, application of 
the more restrictive current definition of scoliosis results in a lower prevalence. Whereas, Kuklova and 
coworkers showed no impact of closure technique(119), Russell reported  the prevalence of sciolosis 
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following muscle flap or patch repair  to be twice that of those following primary closure (13, 15 and 
7%, respectively).(120) Jancelewicz and coworkers noted scoliosis  in 10% of children  who 
underwent non-primary repair.(109)  
Chest wall deformity (i.e. pectus excavatum) occurs in 4-50% of patients (Supplementary Table S7) 
and may relate  to  defect size and closure technique.(119, 120) Jancelewicz et al. reported that mild 
chest deformity was extremely common at all ages, but major deformity requiring referral and 
eventually further treatment occurred in only 8% of patients and at a median age of 5 (range 1.1–6.8) 
years.(108)  
 
Discussion: 
We aimed to evaluate the current practice of long-term follow-up within the CDH EURO Consortium 
centers and to review the literature informing such activity. All respondents agreed that 
standardization of follow-up was needed and were willing to adopt a collectively agreed standardized 
follow-up pathway within the Consortium. Although, follow-up was structured and standardized in 15 
of 19 participating centers, only three centers supported following up all CDH patients without any risk 
stratification. The majority of centers supported review of only those at highest risk of morbidity. Lack 
of resources or personnel were identified as the most important barriers to implementing a structured 
follow-up programme.  
Literature review showed that children with CDH suffer from substantial long-term morbidity across 
several domains. However, most data arises from retrospective chart reviews, usually from single 
centres of small series of patients and the proportion of eligible patients is frequently low or unknown. 
In short, the current literature is insufficient to provide clear guidance on what constitutes ideal follow-
up of children with CDH.  
To optimize long-term care with standardized follow-up for children with CDH, a task force of 
members of the CDH EURO Consortium agreed to use the Standardized Clinical Assessment and 
Management Plans (SCAMP) methodology to establish care pathways. SCAMPs outline a data-
backed, consensus-based, care pathway for a diverse patient population with a particular diagnosis or 
condition.(121) The methodology aims at improving patient outcomes, reduce practice variation, and 
reduce unnecessary resource utilization. Assessment of the effectiveness of diagnostic testing and 
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management interventions is included in the process.(10, 121) This approach, which has been used 
extensively in health care since its introduction in 2009(122), may - in the long run - reduce the 
burden of lack of resources or personnel to perform standardised follow-up. Moreover, it may 
contribute to standardisation of assessments facilitating international multicentre collaboration.(9)The 
first step in the process - which includes formulation of a background position paper based on 
literature review and evaluation of current practice(121, 122) - has been undertaken by the CDH 
EURO Consortium members (Figure 2). This step will be followed by definition of plausible outcomes 
(closely specified statements potentially refutable by accumulating and reviewing unbiased follow-up 
data), identification of entry criteria, and assessment and recommended management algorithms. 
Thereafter, targeted data collection, recorded on SCAMP data forms will followed by iterative data 
analysis enabling modification of the follow-up algorithms.(10, 122) This process will be labor 
intensive and require careful thought. We expect that this initiative will stimulate multicenter 
collaboration within the Consortium and lead to the evidence-based provision of long-term 
multidisciplinary care for CDH patients, and ultimately improved clinical outcomes. With increased 
survival rates after introduction of standardized treatment protocols for CDH patients(3), more children 
will reach adulthood and participate in society. Recommendations for optimal multidisciplinary follow-
up are expected to disseminate into adult care.  
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Figure legends 
Figure 1: 
Current practice of structured and standardized follow-up in 19 CDH centers stratified for the number 
of new CDH cases treated annually. 
 
The x-axis represents the stratification for new CDH cases treated annually per center; the y-axis 
represents the number of centers. 
 
Figure 2: 
Standardised Clinical Assessment and Management Plan (SCAMP) proposal for long-term follow-up 
in congenital diaphragmatic hernia (CDH). 
Figure based on the schematic representation of SCAMPs (solid boxes) proposed by Rathod and 
coworkers.(10) Steps that still need to taken are indicated in italics. a: By consensus seven domains 
of interest were selected: pulmonary morbidity, pulmonary hypertension, neurodevelopmental 
morbidity, sensorineural hearing loss, gastrointestinal morbidity and growth, surgical morbidity and 
musculoskeletal morbidity; b: To explore the feasibility of development of SCAMP and performing 
assessments within the CDH EURO Consortium we performed a survey on current practices of follow-
up of CDH patients (dashed box); c: Multiple plausible outcomes based on literature review of seven 
domains and involvement of patient support groups will be explored simultaneously; d: capture and 
explore deviations(10); e: iterative data analysis and SCAMP modification(10). 
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Table 1: Factors suggested for risk stratification of long-term follow-up in CDH patients 
 
Multiple options were applicable; this question was answered by 17 participants, two centers that 
provide a uniform follow-up program for all CDH patients replied that risk stratification was not 
applicable. Data are shown as n (%). ECMO = extra corporeal membrane oxygenation 
 
Risk factors   
Chronic lung disease 16 (94%) 
Feeding difficulties or growth problems 14 (82%) 
Neurologic morbidity 13 (74%) 
Need for ECMO 11 (65%) 
Mode of closure / use of patch 10 (59%) 
Gastrointestinal issues  9 (53%) 
Observed/expected lung-to-head ratio 4 (24%) 
Pulmonary hypertension / ICU issues 1 (6%) 
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Table 2: Follow-up programs provided within the CDH EURO Consortium centers 
Age of follow-up infancy 15 (100%) 
 toddler 13 (87%) 
 (pre)school 13 (87%) 
 adolescence (>12 yrs) 8 (53%) 
 up till 20 yrs 1 (7%) 
Disciplines involved pediatric surgeon 14 (93%) 
 pediatrician 11 (73%) 
 pulmonologist 11 (73%) 
 pediatric physical therapist 6 (40%) 
 dietician 5 (33%) 
 pediatric cardiologist 5 (33%) 
 speech-language pathologist 4 (27%) 
 psychologist 3 (20%) 
 neonatologist 2 (13%) 
 orthopedic surgeon 1 (7%) 
 clinical geneticist 1 (7%)  
Assessments performed anthropometry (height, weight) 15 (100%) 
 chest radiograph 11 (73%) 
 gastroesophageal reflux 11 (73%) 
 pulmonary function 10 (67%) 
 mental development 8 (53%) 
 motor function development 8 (53%) 
 audiometry 8 (53%) 
 echocardiography 6 (40%) 
 maximal exercise test 5 (33%) 
 social-emotional wellbeing 4 (27%) 
 extensive neuropsychological testing 3 (20%) 
 electrocardiogram 3 (20%) 
 quality of life assessment 3 (20%) 
 intracranial imaging ultrasound 3 (20%) 
 orthopedic assessment 2 (13%) 
 CT chest 1 (7%) 
 ventilation/perfusion scan 1 (7%) 
 intracranial imaging MRI 1 (7%) 
 thoracic MRI 1 (7%) 
 genetic assessment 1 (7%) 
 cardiac catheterization 0 
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Current practice of structured and standardized follow-up in 19 CDH centers stratified for the number of new 
CDH cases treated annually.  
 
The x-axis represents the stratification for new CDH cases treated annually per center; the y-axis represents 
the number of centers.  
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Standardised Clinical Assessment and Management Plan (SCAMP) proposal for long-term follow-up in 
congenital diaphragmatic hernia (CDH).  
Figure based on the schematic representation of SCAMPs (solid boxes) proposed by Rathod and 
coworkers.(10) Steps that still need to taken are indicated in italics. a: By consensus seven domains of 
interest were selected: pulmonary morbidity, pulmonary hypertension, neurodevelopmental morbidity, 
sensorineural hearing loss, gastrointestinal morbidity and growth, surgical morbidity and musculoskeletal 
morbidity; b: To explore the feasibility of development of SCAMP and performing assessments within the 
CDH EURO Consortium we performed a survey on current practices of follow-up of CDH patients (dashed 
box); c: Multiple plausible outcomes based on literature review of seven domains and involvement of patient 
support groups will be explored simultaneously; d: capture and explore deviations(10); e: iterative data 
analysis and SCAMP modification(10).  
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Methodology  
Two-step approach: First, authors of the respective sections of the background position paper 
performed literature searches using disease-specific keywords in Medline. Searches were limited to 
publications published after 2000. In addition, an extensive systematic literature search was 
performed on March 6, 2017 in four different databases: Embase, Medline Ovid, Web of Science and 
Google Scholar. This systematic literature search revealed in total 1695 hits. After exclusion of 
publications before 2000 1295 remained; 1132 of them were excluded based on title/abstract after 
review by one author (H.IJ.). The abstracts of remaining publications were evaluated and based on 
the reported results the publications were classified to be included in the respective domains of long-
term follow-up (i.e. pulmonary morbidity, pulmonary hypertension, neurodevelopment, SNHL, 
growth and gastrointestinal morbidity, surgical morbidity and musculoskeletal morbidity). Then, the 
authors of the respective chapters reviewed the results of the systematic search and added 
references if deemed appropriate. 
 
Embase.com 1273 1257 
Medline Ovid  883 163 
Web of science  760 179 
Google scholar 200 96 
Total  3116 1421 
 
 
Embase.com 1273 
('congenital diaphragm hernia'/exp OR ('congenital malformation'/de AND 'diaphragm hernia'/de) OR 
'Bochdalek hernia'/de OR ((congenital* NEAR/6 diaphragm* NEAR/6 (herni* or defect* OR 
problem*)) OR ((Morgagni* OR bochdalek*) NEAR/3 herni*)):ab,ti) AND ('lung function'/exp OR 
'respiratory function'/exp  OR 'lung function test'/exp OR 'lung disease'/de  OR 'lung hypoplasia'/de 
OR 'exercise test'/exp OR 'pulmonary hypertension'/de OR 'persistent pulmonary hypertension'/de 
OR 'heart function'/exp OR 'echocardiography'/exp OR 'heart catheterization'/exp OR 'mental 
disease'/de OR 'mental development'/exp OR 'mental development assessment'/exp OR 
'intelligence'/exp OR 'motor performance'/exp OR 'motor function test'/exp OR 'hearing 
disorder'/exp OR 'growth'/de OR 'body mass'/de OR 'body size'/de OR 'body weight'/de OR 'digestive 
system function disorder'/exp OR 'feeding difficulty'/exp OR 'recurrent disease'/de OR 'intestine 
volvulus'/exp OR 'intestine obstruction'/exp OR 'malrotation syndrome'/exp OR 'postoperative 
complication'/de OR 'musculoskeletal system'/de OR 'bone'/exp OR muscle/exp OR 'scoliosis'/de OR 
'gastrointestinal symptom'/exp OR 'lung volume'/exp OR 'chronic lung disease'/de OR (((lung OR 
pulmonar* OR respirat* OR heart OR cardiac* OR cardial* OR cardiol* OR cardiopulmon*) NEAR/3 
(function* OR dysfunction* OR test* OR outcome* OR morbidit* OR hypertens* OR pressure*)) OR 
(exercise NEAR/3 (capacit* OR perform* OR Toleran* OR test*)) OR ((chronic* OR longterm* OR 
long-term*) NEAR/3 oxygen*) OR echocardiogra* OR ((heart OR cardiac*) NEAR/3 catheter*) OR 
neurodevelopment* OR ((mental* OR cogniti* OR psychomotor* OR motor OR speech* OR 
language* OR verbal* OR hearing OR auditor* OR development* OR neuromuscul* OR neurobehav* 
OR neurological* OR functional*) NEAR/3 (outcome* OR development* OR performan* OR skill* OR 
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function* OR dysfunction* OR loss OR disorder* OR test* OR assess*)) OR intelligen* OR intellect* 
OR (body NEAR/3 (weight OR mass OR size OR height)) OR digestive OR reflux OR gastrointestin* OR 
gastro-intestin*  OR gastroesophag* OR gastro-esophag*  OR gastroaesophag* OR gastro-aesophag* 
OR feeding OR eating OR (intest* NEAR/3 (adhesion* OR obstruct*)) OR ((surg* OR postsurg* OR 
postop* OR operati*) NEAR/3 (morbid* OR complicat*)) OR recurr* OR relaps* OR volvul* OR 
(small* NEAR/6  (intestin* OR bowel*) NEAR/6 obstruct*) OR malrotat* OR musculoskelet* OR 
skelet* OR scoliosis OR muscle* OR (pulmonar* NEAR/3 (hypoplas* OR resistan*)) OR ((lung OR 
pulmonar*) NEAR/3 (volume* OR chronic*))):ab,ti) AND ('survivor'/de OR child/de OR 'infant'/de OR 
'school child'/de OR adult/exp OR (survivor* OR child* OR schoolchild* OR infan* OR adult* OR long-
term* OR longterm*):ab,ti) NOT ([Conference Abstract]/lim OR [Letter]/lim OR [Note]/lim OR 
[Editorial]/lim) AND [english]/lim AND ('cohort analysis'/exp OR 'follow up'/exp OR 'retrospective 
study'/exp OR 'prospective study'/exp OR 'longitudinal study'/exp OR 'controlled study'/exp OR 
'major clinical study'/de OR 'outcomes research'/de OR (cohort* OR 'follow up' OR followup OR 
retrospectiv* OR prospectiv* OR longitudinal* OR control*):ab,ti) 
Medline Ovid  883 
("Hernias, Diaphragmatic, Congenital"/ OR ("Congenital Abnormalities"/ AND "Hernia, 
Diaphragmatic"/) OR ((congenital* ADJ6 diaphragm* ADJ6 (herni* or defect* OR problem*)) OR 
((Morgagni* OR bochdalek*) ADJ3 herni*)).ab,ti,kf.) AND ("Respiratory Function Tests"/ OR "Lung 
Diseases"/  OR "exercise test"/ OR "Hypertension, Pulmonary"/ OR "Heart Function Tests"/ OR exp 
"echocardiography"/ OR "Cardiac Catheterization"/ OR "Mental Disorders"/ OR "Neurobehavioral 
Manifestations"/ OR "Psychomotor Disorders"/ OR "intelligence"/ OR exp "Psychomotor 
Performance"/ OR exp "Hearing Disorders"/ OR "Growth and Development"/ OR "Body Weight"/ OR 
"Body Size"/ OR exp "Gastrointestinal Diseases"/ OR "Feeding and Eating Disorders"/ OR 
"Recurrence"/ OR "Intestinal Volvulus"/ OR "Intestinal Obstruction"/ OR "Postoperative 
Complications"/ OR "Musculoskeletal System"/ OR exp "Skeleton"/ OR exp Muscles/ OR "scoliosis"/ 
OR "Lung Volume Measurements"/OR "Exercise Tolerance"/  OR (((lung OR pulmonar* OR respirat* 
OR heart OR cardiac* OR cardial* OR cardiol* OR cardiopulmon*) ADJ3 (function* OR dysfunction* 
OR test* OR outcome* OR morbidit* OR hypertens* OR pressure*)) OR (exercise ADJ3 (capacit* OR 
perform* OR Toleran* OR test*)) OR ((chronic* OR longterm* OR long-term*) ADJ3 oxygen*) OR 
echocardiogra* OR ((heart OR cardiac*) ADJ3 catheter*) OR neurodevelopment* OR ((mental* OR 
cogniti* OR psychomotor* OR motor OR speech* OR language* OR verbal* OR hearing OR auditor* 
OR development* OR neuromuscul* OR neurobehav* OR neurological* OR functional*) ADJ3 
(outcome* OR development* OR performan* OR skill* OR function* OR dysfunction* OR loss OR 
disorder* OR test* OR assess*)) OR intelligen* OR intellect* OR (body ADJ3 (weight OR mass OR size 
OR height)) OR digestive OR reflux OR gastrointestin* OR gastro-intestin*  OR gastroesophag* OR 
gastro-esophag*  OR gastroaesophag* OR gastro-aesophag* OR feeding OR eating OR (intest* ADJ3 
(adhesion* OR obstruct*)) OR ((surg* OR postsurg* OR postop* OR operati*) ADJ3 (morbid* OR 
complicat*)) OR recurr* OR relaps* OR volvul* OR (small* ADJ6  (intestin* OR bowel*) ADJ6 
obstruct*) OR malrotat* OR musculoskelet* OR skelet* OR scoliosis OR muscle* OR (pulmonar* ADJ3 
(hypoplas* OR resistan*)) OR ((lung OR pulmonar*) ADJ3 (volume* OR chronic*))).ab,ti,kf.) AND 
("survivors"/ OR exp child/ OR "infant"/ OR adult/ OR (survivor* OR child* OR schoolchild* OR infan* 
OR adult* OR long-term* OR longterm*).ab,ti,kf.) NOT (letter OR news OR comment OR editorial OR 
congresses OR abstracts).pt. AND english.la. AND (exp "Cohort Studies"/ OR "Patient Outcome 
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Assessment"/ OR (cohort* OR "follow up" OR followup OR retrospectiv* OR prospectiv* OR 
longitudinal* OR control*).ab,ti,kf.) 
Web of science  760 
TS=((((congenital* NEAR/5 diaphragm* NEAR/5 (herni* or defect* OR problem*)) OR ((Morgagni* OR 
bochdalek*) NEAR/2 herni*))) AND ((((lung OR pulmonar* OR respirat* OR heart OR cardiac* OR 
cardial* OR cardiol* OR cardiopulmon*) NEAR/2 (function* OR dysfunction* OR test* OR outcome* 
OR morbidit* OR hypertens* OR pressure*)) OR (exercise NEAR/2 (capacit* OR perform* OR 
Toleran* OR test*)) OR ((chronic* OR longterm* OR long-term*) NEAR/2 oxygen*) OR 
echocardiogra* OR ((heart OR cardiac*) NEAR/2 catheter*) OR neurodevelopment* OR ((mental* OR 
cogniti* OR psychomotor* OR motor OR speech* OR language* OR verbal* OR hearing OR auditor* 
OR development* OR neuromuscul* OR neurobehav* OR neurological* OR functional*) NEAR/2 
(outcome* OR development* OR performan* OR skill* OR function* OR dysfunction* OR loss OR 
disorder* OR test* OR assess*)) OR intelligen* OR intellect* OR (body NEAR/2 (weight OR mass OR 
size OR height)) OR digestive OR reflux OR gastrointestin* OR gastro-intestin*  OR gastroesophag* 
OR gastro-esophag*  OR gastroaesophag* OR gastro-aesophag* OR feeding OR eating OR (intest* 
NEAR/2 (adhesion* OR obstruct*)) OR ((surg* OR postsurg* OR postop* OR operati*) NEAR/2 
(morbid* OR complicat*)) OR recurr* OR relaps* OR volvul* OR (small* NEAR/5  (intestin* OR 
bowel*) NEAR/5 obstruct*) OR malrotat* OR musculoskelet* OR skelet* OR scoliosis OR muscle* OR 
(pulmonar* NEAR/2 (hypoplas* OR resistan*)) OR ((lung OR pulmonar*) NEAR/2 (volume* OR 
chronic*)))) AND ((survivor* OR child* OR schoolchild* OR infan* OR adult* OR long-term* OR 
longterm*)) AND ((cohort* OR "follow up" OR followup OR retrospectiv* OR prospectiv* OR 
longitudinal* OR control*))) AND DT=(article) AND LA=(english) 
Google scholar 
"congenital diaphragm|diaphragmatic hernia" "pulmonary|lung|respiratory|cardiac  
function|test|outcome"|"mental|cognitive|psychomotor|motor|developmental|functional 
outcome|development|performance|skills cohort|"follow up"|retrospective|prospective 
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1 
 
Reference 
(population) 
Proportion 
available at FU 
Time frame of FU Main outcome 
parameters 
Outcome description 
Muratore, 2001(1)  
100 CDH, birth 
dates not clear 
 
25 (25%) over five 
years of age 
performed 
pulmonary function 
tests 
Retrospective 
review of a monthly 
multidisciplinary 
clinic between 1990-
1999 
 
Pulmonary function 28% had obstructive  
abnormalities 
Davis, 2004(2) 
73 CDH, born 1991 
to 2000 
100% Retrospective chart 
review 
67 months 
Survival and outcome  48% had respiratory problems, 
59% gastrointestinal problems 
and 19% severe 
neurodevelopmental problems 
Stefanutti, 2004(3) 
24 CDH, born 1985 
to 1994 
24 of 29 (83%) 
patients 
Cross-sectional 8.15 
+ 2.80 years 
Chest radiograph 
ECHO 
Pulmonary perfusion 
Scintography 
Static lung volumes 
and spirometry 
Mean lung function in the 
normal range, 6/24 (25%) 
children had a mild restrictive 
pattern, 3/24 (12.5%) an 
obstructive pattern and 1/24 a 
mixed pattern. Mean perfusion 
to the affected size was 
significantly lower but on both 
sides within the normal range 
 
Arena, 2005(4) 
31 left-sided CDH 
without a patch, 
born 1972 to 2002 
31 of 38 (82%) 
patients 
To assess pulmonary 
function and 
diaphragmatic 
function 
Retrospective, 4.5 
and 21 years 
Chest x-ray 
Diaphragmatic 
ultrasound 
Pulmonary perfusion 
scintigraphy 
Normal life style – no respiratory 
symptoms and reduced 
diaphragmatic mortality 
Trachsel, 2005(5) 
26 CDH, born 1985 
to 1991 
26 of 56 (46%) 
patients 
Cross-sectional 
case-control study, 
13 years 
Pulmonary function 
testing and maximum 
inspiratory and 
48% versus 4% of controls 
showed significant improvement 
of FEV1 after bronchodilator 
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2 
 
expiratory pressures Significant differences in lung 
function results  
Kamata, 2005(6) 
33 CDH, born 1986 
to 2000 
 
All survived beyond 
one year without 
other serious 
congenital anomalies 
Prospective follow 
up  
4.1 + 2.5 years 
Clinical exam 
Growth parameters 
ECHO 
Ventilation and 
perfusion 
Scintigraphy 
Restrictive abnormalities  
Five patients had reduced 
ventilation perfusion 
 
Arena, 2005(4) 
10 CDH, born 1972 
to 1997 
10 of 40 (25%) 
patients 
Cross-sectional, 
prospective 
16 (5-26) years 
Diaphragmatic 
function 
Amplitude of contraction was 
significantly reduced but there 
was no significant difference 
between the two sides 
 
Okuyama, 2006(7) 
31 CDH, born 1996 
to 2002 
100% Prospective, at 1 
and 2 years 
Physical growth and 
pulmonary morbidity  
VP of the ipsilateral lung lower in 
those with pulmonary morbidity 
and lower body weight at one 
and two years 
 
Trachsel, 2006(8) 
1985 to 1991 
32 of 56 (57%) 
patients 
Cross-sectional 
case-control study 
10-16 years 
Pulmonary function 
testing and 
echocardiography 
Exercise capacity was mildly 
reduced in CDH  
Koumbourlis, 
2006(9) 
Not clear 
 
Not clear Retrospective 0-24 
months 
ILFT: FRC, CRS, RRS, 
Vmax FRC 
 
All abnormal at 6 months, 
normalised by 24 months 
Peetsold, 2007(10) 
12 CDH, born 1960 
to 1986 
74% Cross-sectional, 
prospective 24.3 
years 
Pulmonary function,   
diffusion capacity 
exercise capacity 
quality of life 
Lower FEV1 
FEF25-75, than in the general 
population 
Quality of life comparable to the 
general population 
 
Dotta, 2007(11) 100% of survivors Longitudinal, 4.5 ILFT: Tidal volumes, At 4.5 months CDH infants had 
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3 
 
13 CDH, born Jan 
to Dec 2002 
and 11.9 months, 28 
healthy controls 
respiratory rate, 
tPTEF/Te, CRS, RRS, 
FRC, LCI 
lower tPTEF/Te and RR,  
RRS and LCI higher 
At 11.9 months tPTEF/Te lower 
RRS and LCI higher 
 
Hayward, 2007(12) 
46 CDH, born 1990 
to 2005 
46 of 137 (34%) 
patients 
Retrospective chart 
review at 3-5 yrs 
Abnormal V/Q scans 
in two or more 
studies 
Patients who underwent a patch 
repair had nearly seven times the 
risk of having ipsilateral V/Q 
mismatch 
Basek, 2008(13) 
19 CDH, born 1991 
to 2001 
19 of 30 (63%) 
patients 
Retrospective chart 
review 
7.9 ± 2.8 years  
 
Clinical examination 
Lung function tests 
FeNO 
47% had one wheezy episode, 
21% recurrent wheezy episodes, 
47% had lung function 
impairment. Duration of 
ventilation nor the length of 
hospitalisation significantly 
correlated with lung function.  
FeNO was within the normal 
range. 
Masumoto, 
2008(14) 
21 CDH, LHR < 0.2, 
born 1997 to 2005 
Not clear 12 months RSV infection 5/21 (24%) 
required RSV hospitalisation 
Gischler, 2009(15) 
20 CDH (11 ECMO-
CDH, 9 non-ECMO 
CDH), born 1999 to 
2003 
20 of 22 (91%) 
patients 
Longitudinal, 
prospective FU 
6, 12, 24, 60 months 
Pulmonary function 
and maximal exercise 
performance 
10/20 (50%) developed BPD. 
Reduced FEV1 in 25% and 
maximal exercise in 12.5% at 60 
mos. 
 
Roehr, 2009(16) 
26 CDH, born – not 
clear 
Not clear Prospective FU 
44 weeks PCA 
ILFT: Respiratory 
rate, tidal volume, 
FRC, CRS, RRS 
Tidal volume was significantly 
lower, RRS higher, CRS lower 
Peetsold, 2009(17) 
53 CDH non-
53 of 69 (77%) 
patients 
Cross-sectional 11.9 
years 
Spirometry 
Lung volume 
CDH survivors had a lower FEV1, 
FVC, FEV1/FVC 
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4 
 
ECMO, born 1987 
to 1999 
 
Maximal CPET 
Bjorkman, 
2011(18) 
12 CDH, born 2006 
to 2008 
Not clear 6 months SPECT to measure VP 
distribution, 
correlation of VP 
mismatch to 
neonatal clinical 
disease severity 
Correlation co-efficients were 
low 
Turchetta, 
2011(19) 
18 CDH (11 active 
in sport), born 
1994 to 2008 
Not clear Cross-sectional 6.6 + 
2.6 years 
ECG, maximal 
exercise stress test, 
lung function testing 
CDH children who were active 
maintain a higher level of 
performance with less 
perception of dyspnoea and 
effort   
Spoel, 2012(20) 
43 CDH, born 2004 
to 2008 
 
43 of 48 (90%) 
patients 
Longitudinal, 
prospective, 6 and 
12 months 
ILFT: Maximum 
expiratory flow at 
FRC  
and FRC 
Maximum expiratory flow and 
FRC were significantly below 
expected values at 6 and 12 
months.   
Results did not differ according 
to ECMO status 
 
Prendergast, 
2012(21) 
Born 2006 to 2009 
50% 6-24 months ILFT: FRCpleth, Raw, 
FRHe, CRS, RRS 
 
CDH infants had higher FRCpleth 
and lower CRS than those with 
AWD 
Najaf, 2013(22) 
22 CDH, born 2006 
to 2010 
 
22 of 26 (84%) 
patients 
Retrospective chart 
review 
5 years 
? On discharge 40% had 
pulmonary problems at follow up  
Spoel, 2013(23) 
27 non-ECMO 
CDH, born 1975 to 
1986 
27 of 40 (68%) 
patients 
 
Cross-sectional 
case-control study 
26.8 ± 2.9 years 
Dynamic and static 
lung volumes, mid 
expiratory flows, 
diffusion capacity 
Airflow obstruction and diffusion 
capacity deteriorated mildly from 
childhood in survivors of CDH 
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5 
 
 
 
Wright, 2014(24) 
29 CDH, born – not 
clear 
Not clear Retrospective First 3 
years 
ILFT: Raised volume 
Rapid thoraco-
abdominal 
compensation 
technique and 
plethysmography 
 
Air flow obstruction in 14 of 29 
neonates, 
12 obstructive, 
9 restrictive 
Pantich, 2015(25)  
born – not clear 
Not clear Prospective lung 
function 
11-44 months 
ILFT: Raised volume 
Rapid thoracic 
compressions 
technique 
Forced expiratory flows were 
below normal, particularly in 
those who required patch 
closure at ECMO 
 
Healy, 2015(26) 
66 CDH (18 with 
PH), born 2004 to 
2011 
82 of 101 (81%) 
patients 
Retrospective 36 
months 
ILFT: Lung volumes, 
forced flows and tidal 
mechanics 
In those with CDH and PH had 
significantly higher FRC, FRC/TLC 
and RV/TLC 
Cauley, 2015(27) 
201 CDH, born 
1995 to 2001 
83% at one year and 
70% at five years 
Retrospective 
review of 201 
medical records  
5 years 
Adjusting for defect, 
size and presence of 
VP mismatch greater 
pulmonary support at 
30 days was 
associated with 
developmental delay 
at one year and 
asthma and 
developmental 
referral at five years 
 
Supplementary oxygen and 
developmental referral at one 
year 
Asthma and developmental 
referral at 5 years 
Rygl, 2015(28) 
30 CDH, born – not 
Not clear Prospective 
1.32 years 
ILFT: Tidal breathing 
parameters, whole 
High incidence of peripheral 
airway obstruction 
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6 
 
clear body 
plethysmography, 
rapid thoraco-
abdominal 
comparison 
King, 2016(29) 
41 CDH, born 2002 
to 2010 
41 or 43 (95%) 
patients 
6.5 years Association of O/E 
LHR with growth, 
neurodevelopmental 
outcomes, V/Q scans 
Similar outcomes at follow up 
Benoist, 2016(30) 
92 CDH, born 2009 
to 2013 
86 of 92 (93%) 
patients 
Prospective 
Discharge to 24 mos  
Rate of 
hospitalisation for 
wheezing 
56% had wheezing episodes 
Bojanic, 2016(31) 
CDH born 1990 to 
2010 
27 of 38 (71%) 
patients 
 
Cross-sectional 
prospective case-
control study 
7 (5-20) years 
CPET, spirometry  Compared to controls CDH 
survivors had lower anaerobic 
exercise capacity 
Spoel, 2016(32) 
9 CDH (1 ECMO-
CDH), non-
smoking, born 
1975 to 1993 
Not clear 
 
Cross-sectional 28.4 
years (18.1-30.6 
years) 
Hyperpolarised 
3HeMR and 
anatomical 1HMRI 
Functional and microstructural 
changes persist into adulthood 
Ost, 2016(33) 
CDH born 1990 to 
2009 
75% Prospective 
questionnaire Up to 
18 years, range not 
given 
Self-reported health 
and physical status 
Greater problems with asthma  
 
Haliburton, 
2017(34) 
33 CDH, born 1996 
to 2010 
 
33 of 118 (28%) 
patients 
Routine FU 
5-17 years 
Body mass index, 
resting energy 
expenditure and 
pulmonary function 
Mean Z-scores for FEV1 and 
FEV1/FVC were below normal 
Correlation between BMI and 
lung function 
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7 
 
 
ABBREVIATIONS 
1HMRI  1H magnetic resonance imaging 
3HeMR  3He magnetic resonance 
AWD  Abdominal wall defect 
BMI  Body mass index 
BPD  Bronchopulmonary dysplasia 
CDH  Congenital diaphragmatic hernia 
CPET  Cardiopulmonary exercise testing 
CXR  Chest radiograph 
CRS  Compliance of the respiratory system 
DLCO  Transfer factor for carbon dioxide 
ECG  Echocardiography 
ECMO  Extra corporeal membrane oxygenation  
FEF25-75  Mean forced expiratory flow between 25% and 75% of the FVC 
FeNO  Exhaled nitric oxide 
FETO  Fetoscopic tracheal occlusion 
FEV1  Forced expiratory volume at one minute 
FRC  Functional residual capacity 
FRCpleth Functional residual capacity (by plethysmograph) 
FVC  Forced vital capacity 
GORD  Gastro-oesophageal reflux disease 
ILFT  Infant lung function testing 
LCI  Lung clearance index 
LHR  Lung head ratio 
MMV  Maximum voluntary ventilation 
PCA  Post-conceptional age 
RRS  Resistance of the respiratory system 
RCT  Randomised controlled trial 
RSV  Respiratory syncytial virus 
RV  Residual volume 
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SPECT  Single photon emission computed tomography 
TLC  Total lung capacity 
Tptef/tE Time to peak expiratory flow/expiratory time ratio 
Vmax  Maximum flow 
VQ  Ventilation perfusion 
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Reference 
(population) 
Proportion 
available at 
FU 
Time frame of FU Outcome description 
Catheter studies    
Zussman, 2012(1) 
8 repaired CDH, 10 
age-matched controls 
(PDA closure), born 
2007-2010 
8/8 (100%) Retrospective case-
control study. 
8 CDH age 16.9 +/- 9.3 
months. 
 
10 controls age 17.3 +/- 8 
months. 
  
Baseline echocardiographic assessment of PAP using TR and PDA flow.  
Cardiac catheter measurement of PAP and PVR.  
 
Echo findings in CDH group: 3/8 (38%) PAP> 40% systemic BP. 
Catheter data: Mean PAP and PVR significantly higher and pulmonary blood 
flow lower in CDH group. PAP CDH group 23 ± 3 mmHg, Control group 18 ± 
4 mmHg. 
Echo and catheter findings of PH associated with poor growth and 
respiratory symptoms.   
Kinsella, 2005(2) 
7 CDH patients with 
prolonged PH 
referred to PH clinic 
Year of birth not 
stated. 
7/7 (100%)  Age at cardiac 
catheterization: 4 years 
(3 months -12 years)  
Median follow-up after 
catheterization: 12 (6-36) 
months  
Cardiac catheter assessment of  PAP: median(range) 60 (23-66) mmHg 
Additional findings: left PA stenosis/hypoplasia 3/7 (43%),  pulmonary vein 
stenosis/delayed return in ipsilateral lung 6/7,86%; contralateral lung 2/7 
(29%). 
Follow-up: Two deaths from PH at ages 8 years and 19 months.  Therapies: 
O2 n=7, iNO n=2, prostacyclin n=2, bosentan n=1.  
Echo studies    
Trachsel 2006(3)  
23 CDH and 23 
gender/age matched 
controls 
Year of birth not 
stated. 
20/23 (87%) 
CDH  
Cross-sectional, mean 
age 13.2+/- 2.2 years (10-
16) years.   
Echocardiographic assessment of PAP and cardiac function.  Pulmonary 
function and exercise testing.  
Echo data for 20 CDH subjects:  Mean resting RV Resting RV systolic 
pressures 27±6 mmHg : 26-30 mmHg in 4 patients,  31-37 in 3 patients. 
Mean LV ejection fraction 70±7 %. 
Mean ipsilateral PA diameter significantly smaller than  contralateral side, 
but within normal range. 
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Exercise capacity mildly reduced in CDH compared to controls. 
Stefanutti, 2004(4) 
24 children with 
mild/moderate CDH.  
Year of birth not 
stated. 
24/24 
(100%) 
 
Retrospective case study. 
Mean age 8.15 +/- 2.8 
years 
Echocardiographic assessment of PAP using TR estimate of RVSP and 
pulmonary perfusion scanning. 
Echocardiography: RVSP 24.43±3.57 (range 20-30) mmHg.  
Mean LV ejection fraction 68±6 (range 56-68)%, “within normal range for 
age”.  Additional echo findings: moderate TR (n=1), aortic regurgitation 
(n=1) and hypoplastic left PA (n=1). 
Perfusion scans: Mean perfusion to affected side significantly lower. 
Kamata, 2005(5)  56 
infants with high-risk 
CDH; born 1986-2000 
33/56 (59%) Case study, mean age 
11.4 +/- 4.8 years. 
Echocardiographic  assessment, ventilation and perfusion scintigraphy, 
growth assessment. 
“two infants underwent repair of VSD and aortic regurgitation…the others 
had a normal echocardiographic study”. No other echo data reported. 
Dillon, 2004(6)   
57 CDH; single 
centre; born 1991-
2002 
47/57 (82%) Retrospective chart 
review; early outcome 
(60 days) 
Echocardiographic estimation of PAP using TR, expressed as ratio of 
PAP:SBP: PAP<0.5: 23/47 (49%); PAP 0.5-1:16/47 (34%); PAP>1: 8/47 (17%) 
All infants with PAP:SBP>1 at 3 weeks died at 6 weeks. 
Lusk, 2015(7)  
140 CDH (27 died); 
born 2002-2012 
140/140 
(100%) 
Retrospective chart 
review, early outcome 
(until discharge)   
Echocardiographic assessment of PH using hierarchy of PDA flow, septal 
position, TR.   PH severity classification: “No PH”, PAP<2/3 SBP; “moderate 
PH”, PAP=2/3 to SBP; “severe PH”, PAP≥SBP . 
PH resolution  before death or discharge in 98/140 (70%). 
Time to PH resolution ( <2/3 systemic) of PH was 14 (7-21) days. 
15/140 (11%) discharged with at least moderate PH. 
Kipfmueller, 
2017(8) 
26 CDH treated with 
IV sildenafil at single 
institution 
26/26 
(100%) 
(Data only 
on CDH 
patients 
Retrospective chart 
review.  Assessment of 
PH at baseline (first 24 
hours), 14 days, 30 days 
and discharge. 
Echocardiographic assessment of PH using methods and classification as per 
Lusk 2015.  
Baseline (first 24 hours): moderate PH in 10/26 (38.5%), severe PH in 15/26 
(61.5%) infants. 
14 days: No PH or mild PH in 75%  
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meeting 
criteria for IV 
sildenafil 
therapy.) 
 30 days: No PH mild PH in 86%  
Discharge (median 99, range 27-394 days): No PH 84%, mild PH 10%, 
moderate PH 3%. 
Kraemer, 2017(9) 
52 CDH born 2010-
2014 
52/78 (67%) Prospective follow-up at 
6 and 12 months 
Echocardiographic and electrocardiographic assessment of PH.  Four 
patients had persistent PH at follow-up. 
Other echo measures    
Egan, 2012(10) 
7 CDH, 16 controls 
7/7 (100%) Prospective case-control 
study in 7 CDH (6±2 
years) and 16 controls 
(6±2 years). 
 
 
Echocardiographic  assessment of PAP (TR, septal position), RV dimensions 
and RV function (myocardial velocities, and global strain). 
No evidence of PH defined as flattened septum or TR>2.5 
RV and LV function qualitatively normal. 
RV early diastolic and systolic velocities significantly lower in CDH group.  
Non-significant trend of lower global RV strain in CDH group 
No significant differences in RV dimensions or area change. 
Sildenafil use    
Hunter,  2009(11)  
80 CDH; born 2000-
2006 
80/80 
(100%)  
Retrospective case series, 
80 CDH patients.  Age 0-6 
years at follow-up. 
Oral sildenafil use:
22 (28%) of CDH patients received oral sildenafil. 
Sildenafil use increased from 0 to 5 (45%) between 2000-2009. 
Behrsin, 2013(12)   
122 CDH; single 
centre; born 2005-
2012 
122/122 
(100%)  
Retrospective case series.  
Age 0-7 years at follow-
up. 
Oral sildenafil use at discharge and follow-up. 
19/122 (17%) CDH survivors discharged on oral sildenafil. 
Duration of sildenafil after  discharge median (range) 343 (105-671) days. 
Abbreviations: CDH, congenital diaphragmatic hernia; TR, tricuspid regurgitation; PDA, patent ductus ateriosus; PAP, pulmonary artery pressure; PVR, 
pulmonary vascular resistance; PA, pulmonary  artery; SVR, systemic vascular resistance; PH, pulmonary hypertension, iNO, inhaled nitric oxide;  RVSP, right 
ventricular systolic pressure;  
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Reference (population) Proportion 
available at FU 
Time frame of FU Method of outcome 
evaluation 
Outcome description 
Jakobson, 2009(1) 
56 CDH 10-16 years, non-
ECMO (results of same 
cohort described in Frisk 
2011) 
15/56 (27%) Cross-sectional, 10-15.9 
yrs (2 not in analysis 
due to global delay) 
11 controls; 13 CDH 
WISC (IQ); visual and fine 
motor domains (6 subtests 
WISC; 6 additional 
standardized tests); US and 
Canadian references 
2/15 IQ <50 (not tested). Normal overall 
intelligence. Visual motor integration and oral-
motor programming mildly, but sign lower 
than controls 
Peetsold, 2009(2) 
33 high-risk CDH; non ECMO, 
born 1987-1999 
33/40 (83%) Cross-sectional, 6-16 yrs 
(mean (SD) 10.2 (3.3) 
yrs) 
WISC-R; Beery VMI; 
Bourdon Vos (dot 
cancellation test); CBCL; 
TRF; CHQ; HUI (all Dutch 
references) 
IQ 100 +/- 13; VMI normal, sustained 
attention impaired. CBCL: 21% clinical 
problems; TRF 13% clinical problems 
Nijhuis, 2009(3) 
32 ECMO-CDH,  nationwide, 
born 1998-2000 
4/36 (89%) Prospective 5 yrs RAKIT IQ; M-ABC; CBCL (all 
Dutch references) 
Motor function normal in 47%; average IQ 
normal; behavior not different from norm 
Gischler, 2009(4) 
12 ECMO/non-ECMO 
unknown, born 1999-2001,  
unknown Prospective, 
longitudinal 6-12-18-24 
mos 
BOS 2-30 (Dutch 
references) 
Mean mental development normal over time 
(90.1-99.4); mean psychomotor development 
stable over time (82.6-86.1; mild delay) 
Van der Cammen, 2010(5) 
CDH-ECMO (54%), non-
ECMO (46%), born 1999-
2003 
24/37 (65%) Prospective 5 years M-ABC (Dutch references) 58.3% normal motor function (ECMO/non-
ECMO not analysed separately) 
Danzer, 2010(6) 
52 CDH (ECMO 27%; non-
ECMO 73%), born 2004-2007 
41/52 (79%) Prospective, < 4 yrs 
(n=36); >4 yrs (n=5);  
mean (range) 25.4 (6-
62) mos 
BSID-II (< 2006); BSID-III (> 
2006); WPPSI > 4 yr (all US 
references) 
BSID-cognition/ language;average, mixed, 
mildly delayed, and severely delayed in 49%, 
19%, 17%, and 15%, resp. Psychomotor scores 
were normal, mildly delayed, and severely 
delayed in 46%, 23%, and 31%. 31% normal on 
all domains; 16% significanty delayed on all 
domains. WIPPSI below expected. ECMO sign 
predictor poor outcome 
Frisk, 2011(7) (see Jakobson 
2009) 
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Tureczek, 2012(8)  
CDH-nonECMO, born 1994-
2005; without genetic 
syndrome 26/33, with 
genetic syndrome 7/33 
33/39 (85%) Cross-sectional, median 
7.9 years (range 3.3-
14.8 years) 
WPPSI-III (3-6 yrs), WISC-IV 
(> 6 yrs) (German versions, 
reference?), M-ABC-2 (3-5 
yrs) (reference?),  Zurich 
Neuromotor Assessment 
(>5 yrs) (reference?).  
Without genetic syndrome: Cognition normal 
(median (range) 103 (75-121)); >5 yrs 
significantly lower scores on adaptive fine and 
gross motor score (80% abnormal gross motor 
function). Genetic comorbidity only predictive 
factor. 
Danzer, 2013(9)  
CDH-ECMO (26%) and non 
ECMO (74%), n=80, born 
2004-2010 
47/80 (59%) at 
least twice 
Longitudinal, first 
median (range) 8 (5-15) 
mos, last median 
(range) 29 mos (23-36) 
mos 
BSID (II < 2006; III > 2006 
(US references) 
Neurocogn and language: initial: 70% average-
low average; 30% mild-severe delay; last: 76 
vs 24%, resp. Motor: initial: 55% average-low 
average; 45% mild-severe delay; last: 81 vs 
19%, resp. 
Danzer, 2013(10)  
CDH-ECMO (23%) and non-
ECMO (77%), born 2006-?, 
n=60 
60/60 eligible (> 
2yrs) 
Prospective 28 ± 4.5 
mos and 58 ± 4.0 mos; 
most recent evaluation 
in analysis 
BSID-III (n=42) and WPPSI-
III and Beery VMI (n=18);  
(US references) 
BSID-III: 36% mild to severe deficits in at least 
one domain;  7% patients demonstrated 
severe delays for all scales. Mean (SD) scores 
for cognition, language, motor: 90.7 (14.3); 
96.7 (19.1); 92.1 (15.7) WPPSI-III: 103.6 (8.4); 
VMI 89.2 (10.2). ECMO and other severity 
disease assoc low scores 
Wynn, 2013(11) 
CDH-ECMO (14%) and non-
ECMO (86%), born 2007-
2010 multicenter DHREAMS,  
n=53 
49/53 (92%) Prospective 2 years 
(mean 24.6 +/- 1.3 mos) 
BSID-III, VABS-II (US 
references) 
BSID-III: Cogn: 93 +/- 15; language: 95 +/- 16; 
motor: 95 +/-11 (all sign below norm) 
VABS: sign lower scores mean daily living, 
social skills, motor skills. Need for ECMO 
associated dev delay (but only 14%!) 
Benjamin, 2013(12) 
High-risk CDH non-ECMO 
(75%) and ECMO (25%), born 
2001-2005 
16/24 (67%) Cross-sectional  > 4 
years (4.3 to 7.5 yrs) 
WPPSI-III, TELD-3 
(language); US references. 
NCD (neurocogn. delay if 
any score < 80)  
Overall FIQ 89; 44% NCD (median FIQ 81); 56% 
no NCD (median FIQ 99). Expressive language 
< 80 in 33%. 
Madderom, 2013(13) 
n=35, single center, born 
1999-2003 
35/41 (85%) Prospective 8 years; 
CDH-ECMO (n=16); non-
ECMO (n=19) 
RAKIT/WISC; Bourdon-Vos 
(dot cancellation test); M-
ABC (all tests Dutch 
references) 
Mean (SD) IQ ECMO 91.7 (19.5); non-ECMO 
111.6 (20.9). Problems with concentration 
(68%) and with behavioural attention (33%); 
motor function delay in 16% (all irrespective 
groups) 
Madderom, 2013(14) ?; overall ECMO Prospective 8 years RAKIT/WISC; Beery VMI; Mean (SD) IQ 96.6 (18.6); mean (SD) VMI 91.0 
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30 ECMO-CDH, nationwide, 
born 1996-2001 
141/179 (79%) Bourdon-Vos (dot 
cancellation test); (all tests 
Dutch references) 
(16.4); Bourdon-Vos 30% slow-very slow 
working speed. 
Michel, 2013(15) 
31 non-ECMO; 1 ECMO, 
multicenter, born 1999-2008 
32/52 (62%) Cross-sectional 6.7 +/- 
3.3 yrs 
Questionnaires: 
Kidscreen27; SDQ; parents: 
SF-36 (French references) 
Both QoL scores of children and parents 
significantly below the norm 
Leeuwen, 2014(16) 
CDH-non ECMO, born 2006-
2009 
18/29 (62%) Longitudinal 1 (n=18) 
and 3 years (n=15) 
BSID-III; matched controls 
and US references 
Compared to controls normal development; 
compared to reference: At 1 yr 18% severe 
motor delay motor, normal at 3 yrs. At 1 and 3 
yrs 6 and 21% mild delay expressive language  
Van der Cammen, 2014(17) 
49 ECMO-CDH, nationwide 
? (overall ECMO 
254/318 (80%)) 
Prospective, 
longitudinal at 5, 8, 12 
yrs 
M-ABC (Dutch references) Mean (95%-CI) Z-score M-ABC at 5, 8, 12 yrs:  
-0.73 (-0.44 to -1,03), -0.33 (-0.02 to -0.65), 
 -1.48 (0.87 to -2.09) 
Bevilacqua, 2014(18) 
CDH 2008-2010 
(see Bevilacqua, 2015) 
    
Kubota, 2015(19) 
CDH (unknown ECMO or 
not), n=21, born 1992-2003 
(n=53 survivors) 
n=21 (randomly 
invited) from 53 
survivors 
Cross-sectional, 6-17 yrs WISC; CBCL; QoL: Kid-KIND 
Also evaluation (PTSD) of 
mothers. No information 
on references. 
Mean (SD) IQ 80.9 (33.7); T-score CBCL mean 
(SD) 55.3 (10.8); QoL?? (not mentioned) 
Bevilacqua, 2015(20) 
High-risk CDH-non ECMO, > 
33 w gestation, born 2008-
2012 
42/46 (87.5%) Prospective, 
longitudinal 6 and 12 
mos 
BSID-III (Italian, US 
references) 
Mean (SD) mental 92.2 (15.1) and 96.5 (13.7) 
at 6 and 12 mos; mean (SD) motor 92.2 (16.9) 
and 92.9 (17.2) 
Danzer, 2015(21) 
Non-ECMO CDH, born 2005-
2012 (overlap with previous 
studies?!) 
63 consecutive; 
missing data? 
Prospective, 12 mos 
(10-14 mos) 
BSID-III (US references) All scores below normal, mean (SD) mental 
93.7 (14.4), motor 89.6 (14.6), language 
composite 85.9 (13.8). 43% average all scales, 
44% mild delay, 13% severe delay in at least 
one domain. Risk: illness severity, feeding 
problems 
Snoek, 2016(22) 
High-risk CDH, multicentre, 
non-ECMO (93%), ECMO 
81/98 (83%) Prospective, 
longitudinal 12 and 24 
mos; Rome n=39 non-
BSID-II-NL (Dutch) and 
BSID-III (Italian, US 
references) 
Rome: 12 and 24 mos: cognition: mean (SD) 
97.9 (11.8) and 102.1 (13.9); motor: mean (SD) 
93.2 (12.2) and 98.2 (14.8).  
Page 72 of 98
https://mc04.manuscriptcentral.com/prjournal
Pediatric Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
Supplementary Table S3: Neurodevelopmental morbidity 
 
4 
 
(7%), born 2009-2012 ECMO; Rotterdam n=36 
non-ECMO; n=6 ECMO 
(12% of Dutch cohort) 
Rotterdam: 12 and 24 mos: 
cognition: mean (SD) 97.8 (19.8) and 96.0 
(18.4); motor: 87.7 (18.8) and 82.9 (16.7). 
Toussaint, 2016(23) 
26 ECMO-CDH, nationwide, 
born 1996-2004 
(overlap with patients in Van 
der Cammen, 2014(17)) 
?; overall ECMO 
177/251 (71%) 
Prospective 8 yrs M-ABC; SPPC; PedsQL (all 
tests Dutch references) 
Normal motor function in 16/26 (62%); normal 
scores self-esteem and perceived motor 
competence; impaired health status (z-score 
total score mean (SD) -1.43 (1.29)) 
Leeuwen, 2017(24) 
10 ECMO-CDH and 30 non-
ECMO CDH; single centre; 
born 2006-2009 (25 ECMO-
non CDH) 
18/83 (78%) 
overall group 
Prospective 8 yrs WISC-III-NL; extensive 
neuropsychological tests 
(all Dutch references) 
Mean (SD) IQ 84 (12) and 100 (20) in ECMO-
CDH and non-ECMO CDH, respectively. 
Sustained attention, verbal and visuospatial 
memory deficits in whole group. Maximal 
vasoactive inotropic score within first days 
was negatively associated with verbal and 
visuospatial memory 
CDH: congenital diaphragmatic hernia; ECMO: Extracorporeal Membrane Oxygenation; IQ: intelligence quotient; VMI: visuomotor integration; NCD: 
neurocognitive delay 
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Reference (population) Proportion 
available 
at FU 
Time frame of 
FU 
Method of outcome 
evaluation 
Threshold Outcome 
(SNHL) 
Risk factors/notes 
Amoils, 2015(1) 
CDH patients with at least 1 
audiological FU; born 1999-
2008 
50 
(% unknown) 
Mean (range) 
2.7 (0.5-10.7) 
yrs 
Pure-tone audiogram 
(behavioural) 
20 dB 
40 dB 
28/50 (56%) 
9/50 (18%) 
ECMO; L-MV; patch; dose 
furosemide 
Newborn screening normal in 
40/47 (85%) tested  
Dennett, 2014(2) 
Repaired CDH diagnosed < 
12 mos age with at least 1 
audiogram; born 2000-2011 
122/151 
(80%) 
? 
 
Newborn/young infants: 
ABR/Evoked Potentials 
Older: frequency-specific 
behavioural 
20 dB 9/122 (7%) L-MV, L-NICU, LOS, L-
aminoglycosides 
Multivariate: L-aminoglycosides 
Partridge, 2014(3) 
CDH survivors enrolled in 
pulm. hypl program; born 
2004-2012 
112/225 
(50%) 
? 
In theory FU up 
to 3 yrs. 
Newborns: TEOAE, ABR 
Outpatients: behavioural, 
OAE, ABR 
20 dB in 2 
freq. 
SNHL: 3/112 (3%) 
CHL: 38/112 (34%) 
HL NOD 5/112 (4.5%) 
ECMO, L-OS, L-MV, L-diuretics, L-
aminoglycosides, APGAR 5’ 
High prevalence of conductive HL. 
All SNHL diagnosed before NICU 
discharge. 
Wilson, 2013(4) 
High-risk CDH survivors; 
born 2000-2010 
42/44 
(96%) 
? 
In theory FU up 
to 3 yrs. 
AABR/ABR; age-
appropriate audiogram; 
impedance; OAE 
? 1/42 (3%) 1 more pt with mild unilateral 
deficit 
Pt with SNHL had normal screening 
before discharge 
Van den Hondel, 2013(5) 
ECMO-treated CDH 
survivors; born 1992-2005 
24 
(% unknown) 
? 
In theory 6-12-
24 mos 5-8-12 
yrs 
Audiometry 
Tympanometry 
20 dB 2/24 (8%) No difference between CDH and 
other diagnosis 
Safavi, 2012(6) 
CDH survivors 2 centres; 
born 2005-2007 
44/44 
(100%) 
? 
Up to 10 yrs 
? ? 5/44 (11%) Multicenter study with different FU 
programs 
Morando, 2010(7) 
High-risk CDH survivors; 
born 2003-2009 
26/32 
(81%) 
Median (IQR) 2 
(1-4.5) 
Newborns: A-TEOAE/A-
ABR 
Older: behavioural; OAE; 
tympanometry; acoustic 
reflex 
20 dB in 2 
freq. 
1/26 (4%) 
CHL: 4/26 (16%) 
Patients with SNHL had normal 
newborn screening. 
4 patients had only newborn 
screening 
Javidnia, 2009(8) 17/19 ? ? ? 6/17 (35%) Normal neonatal screening in 5 
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CDH survivors; born 1998-
2006 
 
(90%) 
L-NICU, L-MV 
Morini, 2008(9) 
High-risk CDH-non ECMO; 
born 1999-2005 
82/87 
(94%) 
Median (IQR) 3 
(1.4-4.5) yrs 
< 12 mos: OAE or AABR 
Older: repeated 
behavioural  audiometry   
20 dB 40/82 (49%) Univariable: GA, L-MV, L-
aminoglycosides, L-pancuronium, L-
diuretics, iNO, age at test, N. sepsis, 
N. hypocapnia 
Multivariable: age at test 
Masumoto, 2007(10) 
High-risk CDH survivors; 
born 1997-2005 
16/18 
(89%) 
Range 1-8 yrs <12 mos: A-ABR 
Older: A-ABR; behavioral 
30 dB 4/16 (25%) Normal neonatal screening in all 
L-MV, L-HFOV, L-diuretics, L-
pancuronium, Dose pancuronium 
Fligor, 2005(11) 
CDH surivors treated ECMO; 
born 1986-1994 
22 
(% unknown) 
? 
Up to 42 mos 
ABR; behavioural 20 dB or 30 
dB 
depending 
on freq. 
and test 
13/22 (59%) CDH independent risk factor in 
ECMO graduates. 
L-ECMO; L-aminoglycosides 
Cortes, 2005(12) 
Severe L-CDH survivors 
(LHR<1.4); born 1999-2001 
16 
(% unknown) 
36 mos Newborn: A-ABR 
Older: Clinical, if concern 
>> behavioural 
? 8/16 (50%)  
(7 require 
amplification) 
Normal neonatal screening in 6. 
Progressive increase of prevalence 
with ageing. 
Robertson, 2002(13) 
Severe CDH survivors (2 
OI>25 15 min apart; born 
1994-1996 
15/15 
(100%) 
48 mos Newborn: ABR; 
TEOAE/DPOAE 
Post-discharge: 
tympanometry; 
developmental-
appropriate behavioural; 
ABR, TEOAE 
18-24 mos: 
40 dB 
4 yrs:  25 
dB 
15/15 (100%) No difference between ECMO-
treated and non-ECMO-treated 
patients 
Jaillard, 2002(14) 
CDH survivors; born 1990-
1998 
51/51 
(100%) 
24 mos Boel test; brainstem 
auditory-evoked potential 
? 0/51 (0%)  
Rasheed, 2001(15) 
CDH survivors ECMO 
graduate; born 1984-1994 
15/21 
(71%) 
Mean (range) 
7,4 (3-9) yrs 
Tympanometry, 
behavioural 
30 dB or 
need for 
ampl. 
8/15 (53%) L-ECMO, L-furosemide, L-alkalosis 
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Abbreviations: ABR: auditory braistem response; A-ABR: automated ABR; CDH: congenital diaphragmatic hernia; CHL: conductive hearing loss; ECMO: 
extracorporeal membrane oxygenation; FU: follow-up; GA: gestational age; HFOV: high frequency oscillatory ventilation; L: length; LOS: length of stay; MV: 
mechanical ventilation; NICU: neonatal intensive care unit; NOD: not otherwise defined: OAE: otoacoustic emissions; SNHL: sensorineural hearing loss: 
TEOAE: transient evoked OAE 
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Supplemental Table S6: Surgical morbidity 
 
Reference (population) Proportion available at 
FU 
Time frame of FU Method of outcome 
evaluation 
Outcome description 
Nagata, 2015(1) 
180 CDH; nationwide 
(questionnaire, incomplete 
data); born 2006-2010 
 
180/228 (79%)  survived at 
least 3 yrs 
2 year follow up 
 
Recurrence rate at 6-12-
24 months; multivariate 
analysis 
 
Recurrence total: 21 (11,7%); 
primary 5.4%, patch 22.1 %.  
liver herniations significant 
predictor (OR 3.96; 95% CI 
1.01-16.92).Patch and defect 
size C+D not significant. 
Jancelewicz, 2013(2) 
157 CDH; born 2000-2011; 
single centre 
157/187 patients  84%; (27 
died, 3 excluded due to lack 
of follow-up), FU 0.7-12.3 
years 
Retrospective; based on 
follow-up protocol: 4wk 
(post discharge)-4mos-
8mos-12mos-18mos-2yrs-
3yrs-5yrs-7yrs-10yrs 
X-ray for recurrence 
SBO 
Laparotomy  
Chest wall deformities 
Scoliosis 
Recurrence all 15% (MIS 32% 
versus open 11%, patch 29% vs 
primary 10%) 
Median time to recurrence 
0.7y (range 0-8.5), primary 0.4 
(0-5.1), patch 1.4 (0-8.5) 
SBO laparotomy primary 6%, 
patch 12%  
 
St Peter, 2007(3) 
121 CDH, born 1994-2004 
single centre 
67% (81 of 121 survived 
repair) 
Retrospective; FU 2.2-12.9 
yrs (mean 8 yrs). Patch 
(n=24) versus primary (n=57) 
repair. 
Small bowel obstruction 
Recurrence 
Fundoplication 
Subsequent abdominal 
operation 
Patch 21% vs primary 5% 
Patch 25% vs primary 7% 
Patch 21% vs primary 11% 
Patch 63% vs primary 18% 
Jancelewicz, 2010(4) 
99 CDH; born 2000-2008; 
single centre 
different patch material over 
time period (Goretex  or 
Surgisis until 2006, Goretex 
and Surgisis after 2006) 
98 (99%) survivors, 1 death 
after discharge 
Prospective FU 2000-2008 Recurrence  
 
 
 
 
Bowel obstruction and 
laparotomy 
 
Primary 10% versus patch 46%, 
hazard ratio patch (versus 
primary) 5.4 (2-16). 
Median time to recurrence 
primary 1.2 yrs, patch 0.9 yrs. 
13% total, median 1.2 yrs 
(range 0.1-3.6 yrs). (54% 
adhesions, 39% reherniation, 
8% volvulus). 
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Davis, 2004(5) 
27 CDH-ECMO; born 1992-
2000 
(27/73 /37%) survived  Retrospective  
 
Recurrence 
Malrotation 
Other abdominal surgery 
11% (3/27) 
11% (3/27) 
11% (3/27) 
Crankson, 2006(6) 
31 CDH, born 1993-2002  
31/45 newborns (69%), 14 
died (31% in total, 24%  in 
neonatal period)  
Retrospective; FU 6 mos-9 
yrs (no structured FU) 
 
Recurrence 
SBO 
Laparotomy for SBO 
13% (4/31) 
23% (7/31) 
10% (3/31) 
Tsai et al, 2012(7) 
149 corrected CDH; born 
1999-2010;  
149/184 (81%) (85 (46.2%) 
primary and 99 (53.8%) 
patch repair in total) 
75 (50.3%) primary and 74 
(49.7%) patch repair in 
survivors) 
Retrospective; FU median 18 
mos primary, 24 mos patch 
(no structured FU) 
Main: recurrence  
Secondary:  
SBO 
SBO with operation 
Patch infection 
 
Primary 4%, patch 5.4% 
 
Primary 6.7%, patch 5.4% 
Primary 4%, patch 5.4% 
Not stated  
Cho et al, 2009(8) 
57 CDH; born 2001-2004; 29 
thoracoscopic,  28 open 
repair 
29/72 thoracoscopic (40%) 
28/72 open (39%), 15/72 
(21%) died 
Retrospective, FU 2wk-1mo-
every 3-6mos until 2 yrs (no 
structured FU) 
 
Recurrence 
 
Thoracoscopic 6/29 (21%) 
Open 2/28 (7.1%) 
Yokota, 2014(9)  
83 CDH; born 1995-2013 and 
240 newborns with open 
laparotomy 
 
74/83 (89%) children with 
CDH, 49 primary and 25 
patch repair, 240 controls 
with abdominal procedures 
Retrospectiv  case-control 
study;  FU median 50 mos 
(4-225) 
SBO reoperation 
 
Recurrence 
17.6% with CDH 
6.7% control group  
10.8% 
Laituri, 2010(10) 
155 children with CDH; born 
1994-2009 
3 types of patch: 37 Surgisis, 
12 nonabsorbable (Dacron 
and Gore-Tex), 5 AlloDerm 
155 survivors, died children 
excluded.  
101 primary and 54 patch 
repair. 
 
Retrospective, survival not 
named (excluded, no 
numbers) and length of FU 
not named.  
Recurrence 
 
 
 
Re-recurrence 
 
 
SBO 
 
 
 
Subsequent abdominal 
Primary 7 % 
Nonabsorbable 50% 
vs Biosynthetic 24% 
 
Nonabsorbable 67% 
Biosynthetic 50% 
 
Primary 9% 
Nonabsorbable 17% 
vs Biosynthetic 21% (ns) 
 
Primary 17% 
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operations Nonabsorbable 67% 
vs Biosynthetic 48% (ns) 
Janssen, 2017(11) 
132 CDH, born 2000-2014 
132/177 (74.6%) survivors, , 
112/132 (84.8%) eligible 
(because of > 2 year FU) 
Retrospective, at least 2 
years FU (mean 7.3 years); 
With/without ECMO and 
with/without patch 
evaluated as independent 
risk factors. 
Recurrence 
 
 
SBO 
 
 
 
Subsequent abdominal 
surgeries (fundoplication 
and/or gastrostomy) 
7% total 
patch 14%, primary 4%;  
23% after ECMO, 3% without; 
20% total 
patch 29%, primary 16%; 
9% after ECMO, 22% without 
ECMO 
11/8% total 
patch 20%/20%, primary 
7%/3% primary 
18%/18% after ECMO, 9%/6% 
without 
Criss, 2017(12) 
51 CDH, born 2006-2016; 16 
open repair, 35 
thoracoscopic 
 
? Retrospective, median FU 2 
years (range from 1-102 
month) 
Recurrence (side not 
mentioned) 
Overall recurrence 13.7%, 6.3% 
open, 17.1% thoracoscopic 
Putnam, 2017(13) 
3067 CDH in CDH Registry, 
84% open, 16% MIS 
? Retrospective, unclear 
length of FU or if data are 
complete 
Recurrence 
 
SBO 
13 % open, 18.4% MIS 
 
19.4% open, 2.3% MIS 
Ward, 2017(14) 
2379 CDH in Pediatric Health 
Information System US, born 
2009-2016 
2379/3051 (78%)survived  Retrospective, comparing 
preemptive Ladd’s 
procedure or not and 
occurrence of volvulus 
Volvulus Not significant  
No Ladd: 6/2259 (0.3%) 
Ladd: 0%  
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Reference (population) Proportion 
available at FU 
Time frame of FU Method of 
outcome 
evaluation 
Outcome  
scoliosis 
Outcome chest wall 
deformity 
Safavi, 2012(1) 
CDH, born 2005-2007 
44/44 
Liveborn: 54 
Survivors:  44 
24-36 mos Not defined 1/44 (2%) PE 2/44 (4%) 
Rocha, 2012(2) 
CDH, born 1997-2010 
39/39 
Survivors: 39 
70 mos (4-162) Not defined 4/39 (10.2%)  PE 6/39 (15.3%) 
Kuklova, 2011(3)  
CDH, born 1996-2009 
 
53/120 
Treated: 164 
Survived 120 
Participated: 53 
7 yrs (range not 
given) 
1. PE: clinical 
evaluation 
2. Scoliosis: 
 CA > 5 degrees 
 
14/53(26%)  
 
PE 25/53 (47%) 
Related to defect 
Takayasu, 2016(4) 
CDH, born 2006-2010 
 
159/182 
Born: 674 
Survivors: 444 
Enrolled 182 
4.3 yrs (1.3-7.6) Not defined 20/159 
(12.6%) 
PE: 19/159 (11.9%)  
Chest  asymmetry: 12/159 
(7.5%) 
Jancelewicz, 2013(5) 
CDH, born 2000-2011 
157/160 
Treated 187 
Survivors: 160 
Studied: 157 
0.7-12.3 yrs Scoliosis: clinical 
evaluation/selec
ted  sequential 
imaging 
4/157 (3%) 
(Only patch 
pts) 
Major chest deformity: 
13/157 (8%) 
Russell, 2014(6) 
CDH, born 1989-2012 
Chart review of 
all 279 operated 
Operated: 279 
Survived:  236 
0.5 – 23.8 yrs Clinical 
evaluation and 
as reported in 
chart 
25/279 (9%) 59/279 (21%) 
 
Koziarkiewicz, 2014(7) 
50 CDH, born? 
? 3 mos-18 yrs Scoliosis:  
CA>15 degrees 
6/50 (12%) Chest deformity 20/50 
(40%) 
Chest asymmetry 8/50 
(16%) 
PE: pectus excavatum 
CA: Cobb’s angle 
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